Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients
Clinical trial NCT01613300 · COMPLETED
Trial details
- NCT number
- NCT01613300
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-04
- Primary completion
- 2016-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.